pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$ANIPANI PHARMACEUTICALS INC

$ANIP68.55-0.84%
Princeton, NJ, USupdated 2h ago
Website ↗SEC EDGAR ↗Yahoo Finance ↗
community read0 votes
pipeline
7
marketed
7
phase 3
0
catalysts ytd
6
approvals ytd
2
recalls ytd
0

Pipeline(7)

pipeline depth7 products
Marketed: 7
7Marketed
Marketed
Chewtadzy
Storage Symptoms of Benign Prostatic Hyperplasia
Marketed
Cortenema
Proctitis
Marketed
REGLAN
Diabetic Gastroparesis
Marketed
fluvoxamine maleate
Obsessive-Compulsive Disorder
Marketed
lithium carbonate ER
Bipolar Disorder (Manic Depression)
Marketed
sinecatechins
Genital Warts (Condylomata Acuminata)
Marketed
vancocin hydrochloride
Enterocolitis

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

earnings (2)
Nov 6, 2026
earnings
$ANIP68.55-0.84%
15d ago
ANI PHARMACEUTICALS INC earnings
ANI PHARMACEUTICALS INC
→
Nov 5, 2026
earnings
$ANIP68.55-0.84%
16d ago
ANI PHARMACEUTICALS INC earnings
ANI PHARMACEUTICALS INC
→
view all catalysts →
🐶 Hiring Signal
No open roles indexed yet — view ANI PHARMACEUTICALS INC jobs →

News

  • BioNTech pays $205M for FDA voucher to speed up ‘late-stage oncology pipeline’
    BioNTech has agreed to pay $205 million to purchase an FDA priority review voucher to support a future filing of a drug in its “late-stage oncology pipeline.” Fierce breaks down which candidate is…
    fiercebiotech · 9d ago
  • Lilly, Hims reach GLP-1 deal; Alnylam sales chief to step down
    The deal is part of a course change for Hims, which had previously sold knockoff GLP-1 drugs. Elsewhere, a medicine Servier recently acquired failed a key trial and Ultragenyx announced staff cuts.
    biopharma_dive · 14d ago
  • Rasonque sales drive RevMed's stock; whistleblower sues Madrigal over MASH
    Plus news about Rezera, ANI Pharmaceuticals, Cloudbreak Pharma and Anaheim Bio. RevMed’s stock jumps on early Rasonque sales: The RAS drug developer reported sales of its pancreatic cancer therapy…
    endpoints · 15d ago
  • Trump threatens tariffs on imported generic drugs
    While the possibility of levies on branded pharmaceuticals have had a limited impact on drugmaker revenues, tariffs of up to 200% on copycat medicines could — depending on the specifics — prove mor…
    biopharma_dive · 4mo ago
identifiers
ticker
$ANIP
SEC CIK
0001023024
country
US
source
sec_tickers
top tags
Infectious Disease1
mentioned in
4news items
entity-linker matched
Data sources
SEC EDGAR · openFDA
last refreshed 26m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?